Glycopyrrolate Injection, Solution
Product Images NDC 0517-4605

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0517-4605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4d517ecd-figure-01 (Glycopyrrolate Injection 1)

Chemical structure diagram of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight of 398.33. The diagram illustrates the molecular arrangement including rings, oxygen, nitrogen, and bromine atoms.*

FDA Label Image

Glycopyrrolate Injection 10

The image shows a medication label section for Glycopyrrolate injection, solution with strength 0.2 mg/mL by American Regent, Inc. It features a 2D barcode and printed information including lot number (0000), expiration date (01/2099), GTIN (00305174601252), and serial number (0). The label indicates product traceability data.*

FDA Label Image

Glycopyrrolate Injection 11

A label featuring a 2D barcode above black text showing batch and product information. The text includes LOT number 0000, an expiration date of 01/2099, a GTIN code 00305174602259, and an SN number 0. The label is plain white with no additional visible branding or dosage details.*

FDA Label Image

Glycopyrrolate Injection 12

A label containing a 2D barcode with printed text below displaying lot number, expiration date (01/2099), GTIN, and serial number. No product name or dosage details are visible on this part of the label.*

FDA Label Image

Glycopyrrolate Injection 13

A small label featuring a QR code along with printed text indicating lot number 0000, expiration date 01/2099, GTIN 00305174620253, and serial number 0. No product name or other details are visible on this label.*

FDA Label Image

1 mL Container (Glycopyrrolate Injection 2)

Label for Glycopyrrolate injection, USP 0.2 mg/mL in a 1 mL single-dose vial for intramuscular or intravenous use. The label states Rx Only and is manufactured by American Regent, Inc., Shirley, NY. It includes storage instructions to keep at 20° to 25°C (68° to 77°F) and a warning to discard unused portions. A barcode and lots/expiration fields are present.*

FDA Label Image

2 mL Container (Glycopyrrolate Injection 3)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL single-dose vial for intramuscular or intravenous use. The label includes storage instructions, discard warnings, and notes that it is Rx only. The product is labeled by American Regent, Inc., Shirley, NY.*

FDA Label Image

5 mL Container (Glycopyrrolate Injection 4)

Label for Glycopyrrolate injection, USP 1 mg/5 mL (0.2 mg/mL) multiple dose vial for intramuscular or intravenous use. The vial contains 5 mL of solution. The label indicates it is Rx only and manufactured by American Regent, Inc., Shirley, NY. The label also lists inactive ingredients including Benzyl Alcohol 0.9% and note on adjusted pH with Sodium Hydroxide and Hydrochloric Acid, with storage instructions at 20° to 25°C.*

FDA Label Image

20 mL Container (Glycopyrrolate Injection 5)

Label for Glycopyrrolate Injection, USP, 4 mg per 20 mL (0.2 mg/mL) multiple dose vial for intramuscular or intravenous use. The label states Rx Only, is from American Regent, Inc., and includes ingredient details, storage instructions, and a barcode.*

FDA Label Image

1 mL Carton (Glycopyrrolate Injection 6)

Label of Glycopyrrolate injection, USP 0.2 mg/mL solution for intramuscular or intravenous use, in single dose vials. The label shows the NDC number 0517-4601-25, package size 25 x 1 mL, and is labeled for prescription use only. Manufactured by American Regent, Inc., Shirley, NY.*

FDA Label Image

2 mL Carton (Glycopyrrolate Injection 7)

Label for Glycopyrrolate injection, USP, 0.4 mg/2 mL (0.2 mg/mL) in single dose vials, 25 vials of 2 mL each. Suitable for intramuscular or intravenous use. Manufactured by American Regent, Inc. Label includes storage instructions and a barcode.*

FDA Label Image

5 mL Carton (Glycopyrrolate Injection 8)

Label for Glycopyrrolate injection, USP 1 mg/5 mL (0.2 mg/mL) solution by American Regent, Inc. It is indicated for intramuscular or intravenous use and packaged as multiple dose vials, 25 vials of 5 mL each. The label includes storage instructions and active ingredient details.*

FDA Label Image

20 mL Carton (Glycopyrrolate Injection 9)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) multiple dose vials by American Regent, Inc. The injection is for intramuscular or intravenous use. The label includes NDC 0517-4620-25 and states the container holds 25 vials of 20 mL each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.